Website address: www.sparktx.com/we-are-spark/
Company contacts: Spark Therapeutics, Inc.
3737 Market Street
Philadelphia, PA 19104 USA
Spark Therapeutics, a fully integrated company, strives to challenge the inevitability of genetic disease by discovering, developing, and delivering gene therapies that address inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver.
No product(s)/service information available
Website address: www.sifigroup.com
Company contacts: Product Communication
- Roberta Mazzarino - email@example.com
- Agata Basile - firstname.lastname@example.org
- Hyalistil Bio
- Hyalistil Plus
- Azyr Mega
- AVS Retina
ILUVIEN - Retina
Website address: www.secondsight.com
Company contacts: Tel +41 21 353 02 71
Fax +41 21 353 02 72
Second Sight Medical Products (Nasdaq: EYES),founded in 1998, is a medical device company that develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients.
Our current product, the Argus® II Retinal Prosthesis System, is intended to provide electrical stimulation of the retina to induce visual perception in blind people with outer retinal degenerations, such as Retinitis Pigmentosa (RP). Argus II is approved for use in the United States (FDA) since 2013 and European Economic Area (CE Mark) since 2011.
Argus® II Retinal Prosthesis System